Information  X 
Enter a valid email address

Baillie Gifford Shin (BGS)

  Print      Mail a friend

Wednesday 18 September, 2019

Baillie Gifford Shin

Half-year Report

RNS Number : 8585M
Baillie Gifford Shin Nippon PLC
18 September 2019
 

RNS Announcement

 

This announcement replaces the announcement released on 17 September 2019 (RNS Number: 5074M).

There has been an amendment made to the Twenty Largest Equity Holdings table.

 

Baillie Gifford Shin Nippon PLC

 

Legal Entity Identifier: X5XCIPCJQCSUF8H1FU83

Regulated Information Classification: Half Yearly Financial Report

 

Results for the six months to 31 July 2019

 

 The Company's net asset value per share rose by 15.3% compared to a 9.8% rise in the MSCI Japan Small Cap Index*. The share price increased by 8.1%.

 

¾   Although the Japanese market remained sluggish, sterling based investors benefitted from currency weakness against the Japanese Yen.

¾   Longstanding holding GMO Payment Gateway was the largest positive contributor to performance. Its core online payments processing business continues to grow rapidly.

¾   Most of the weak performers in the first half of the year were cyclical companies with exposure to global demand.

¾   New purchases included Kitanotatsujin, a fast growth, specialist online cosmetics company, and Tsugami, a specialist machine tool maker.

 

†   After deducting borrowings at fair value.

*   The Company's comparative index is the MSCI Japan Small Cap Index (total return and in sterling terms). See disclaimer at the end of this announcement.

 

Source: Refinitiv/Baillie Gifford and relevant underlying index providers. See disclaimer at end of this announcement.

Shin Nippon aims to achieve long term capital growth through investment principally in small Japanese companies which are believed to have above average prospects for growth. At 31 July 2019 the Company had total assets of £562.3million (before deduction of bank loans of £56.0million).

The Company is managed by Baillie Gifford, an Edinburgh based fund management group with approximately £207 billion under management and advice as at 16 September 2019.

Past performance is not a guide to future performance. The value of an investment and any income from it is not guaranteed and may go down as well as up and investors may not get back the amount invested. The Company has borrowed money to make further investments. This is commonly referred to as gearing. The risk is that, when this money is repaid by the Company, the value of these investments may not be enough to cover the borrowing and interest costs, and the Company makes a loss. If the Company's investments fall in value, gearing will increase the amount of this loss. The more highly geared the Company, the greater this effect will be.

Investment in investment trusts should be regarded as long term. You can find up to date performance information about Shin Nippon at www.shinnippon.co.uk.

 

16 September 2019

 

 

For further information please contact:

 

Alex Blake, Baillie Gifford & Co

Tel: 0131 275 2859

 

Roland Cross, Director, Four Broadgate

Tel: 0203 697 4200 or 07831 401309

 

 

 

 

The following is the unaudited Interim Financial Report for the six months to 31 July 2019.

 

Responsibility Statement

 

We confirm that to the best of our knowledge:

a)  the condensed set of Financial Statements has been prepared in accordance with FRS 104 'Interim Financial Reporting';

b)  the Interim Management Report includes a fair review of the information required by Disclosure and Transparency Rules 4.2.7R (indication of important events during the first six months, their impact on the Financial Statements and a description of the principal risks and uncertainties for the remaining six months of the year); and

c)  the Interim Financial Report includes a fair review of the information required by Disclosure and Transparency Rules 4.2.8R (disclosure of related party transactions and changes therein).

 

On behalf of the Board

MN Donaldson

Chairman

16 September 2019

 

 

 

 

 

Interim Management Report

 

During the first half of this year, we witnessed anaemic market conditions driven primarily by macroeconomic concerns. Investors remained cautious due to the ongoing US-China trade war and slowing economic growth across key geographies. Unsurprisingly, Japanese equities remained under pressure during this period. High growth smaller companies and cyclical businesses with meaningful overseas sales were especially hard hit as investors sought refuge in high yielding sectors with dull growth prospects. Despite these short-term cyclical headwinds, we remain confident that the disruptive, high growth stocks that we own in the portfolio are well positioned to deliver attractive returns over the medium and long term.

Although the Japanese market remained sluggish, sterling-based investors benefitted from currency weakness against the Japanese Yen. In the six months to 31 July 2019, Shin Nippon's net asset value per share (after deducting borrowings at fair value) rose by 15.3% compared to a 9.8% rise in the MSCI Japan Small Cap index. Over three and five years, which we believe is a fairer way of judging long-term investment performance, the comparative index is up by 29.8% and 92.2% respectively, while the Company's net asset value per share is up by 63.8% and 193.4%.

Longstanding holding GMO Payment Gateway was the largest positive contributor to performance. Its core online payments processing business continues to grow rapidly but more encouragingly, its newer businesses such as payment after delivery and remittances are also gaining traction. These new growth areas have become meaningful parts of the overall business. It also recently announced a joint venture with Visa and Sumitomo Mitsui Financial Group, one of the largest financial institutions in the world, to build a next generation payment platform in Japan. The Japanese government is aggressively promoting cashless payments as it seeks to reduce Japan's high dependency on cash-based transactions. We believe GMO Payment Gateway will be a big beneficiary of Japan's structural shift towards a cashless economy.

Online legal consultation website Bengo4.com was another strong performer. With just over 40% of all lawyers in Japan as its registered members, Bengo4.com is rapidly becoming the service of choice for seeking online legal advice in Japan. Even more exciting are the growth prospects of Cloudsign, a cloud-based contract service that Bengo4.com launched a few years ago. As an online service offering documents that can be prepared, analysed and signed electronically, Cloudsign speeds-up the contract signing process between businesses, reduces costs and increases transparency. Adoption of Cloudsign continues to be rapid, with nearly 50,000 companies having signed up to use this service since it was introduced.

Another notable strong performer was Asahi Intecc, a leading global manufacturer of guidewires and catheters used in cardiovascular surgery. Following the termination of its joint venture with US healthcare company Abbott Labs last year, Asahi Intecc has taken full control of its distribution in North America and is already seeing its share increase in this market as a result. It also recently launched products targeting new areas like neurovascular surgery where the size of the addressable market is much larger than the cardiovascular market.

Given the challenging business environment globally, most of the weak performers in the first half of the year were cyclical companies with exposure to global demand. Plastic car parts manufacturer DaikyoNishikawa mirrored the dwindling fortunes of its main customer Mazda. The latter is seeing declining sales in both the US and China as its newer models are struggling to gain traction and this is having a significant negative impact on DaikyoNishikawa's business. Industrial security sensor manufacturer Optex has seen a slowdown in growth in its core sensors business. It is also suffering from weak demand in its factory automation division largely due to the ongoing trade tariffs related issues. Megachips, a fabless manufacturer of electronic components for gaming consoles and consumer electronics, saw considerable share price weakness following the cancellation of a large order by a major client.

Thanks to our long-term investment horizon, portfolio turnover remained low at 15%. However, a few new holdings were purchased. Among these was Kitanotatsujin, a fast-growing, specialist online cosmetics company. It has a good track record of developing unique and highly effective products targeted at improving specific skin conditions. Its subscription-based business model sets it apart from its peers, generating a high proportion of recurring revenues which tend to be higher margin.  It is run by its young and dynamic founder who retains a large stake in the business, thereby ensuring a high degree of alignment with minority shareholders. We also took a holding in Tsugami, a specialist machine tool maker that has high market shares and is growing rapidly in both China and India, two of the most promising end markets globally. Litalico was another new addition to the portfolio. It provides training and employment assistance for disabled people as well as educational services for children with developmental difficulties. This is a hugely underserved market in Japan, with a sizeable target population. The government has put in place policies to increase the employment opportunities for disabled people, especially in view of the upcoming Paralympic Games to be held in Tokyo in 2020. This should benefit Litalico which is one of the few players with a nationwide support coverage. More generally, the pool of exciting high growth smaller businesses in Japan continues to rise as witnessed by the increasing number of IPOs of such businesses. We are also observing a similar trend amongst unlisted companies. Although we currently have only one unlisted stock in the portfolio, in line with the mandate passed at the AGM, we continue to look for opportunities in this space.

We also sold a few positions completely during the first half of this year. Among these was SanBio, a biotech company developing a stem-cells based treatment for brain injury related stroke. In a hugely disappointing outcome, the company suffered a major blow with the failure of a critical trial of this treatment. Asics, a leading global brand of running shoes, was another stock that was sold. In recent years, management have failed to respond adequately to competitive pressures, resulting in Asics falling behind its traditional rivals like Nike and Adidas. Given our lack of faith in management's ability to turn the business around, we decided to sell our holding in the company. We also sold our holding in high-end condominium builder Mugen Estate as it is facing a perfect storm of rising land acquisition costs and declining demand.

Global markets are currently experiencing high levels of uncertainty and Japan is no exception. The slowdown in economic growth across many large economies is being exacerbated by the ongoing trade war between the US and China. It is natural to expect market weakness in these conditions as investors adopt a cautious approach towards equities in general. However, for us as long-term growth investors, the current environment is giving rise to numerous exciting investment opportunities. Many high quality and rapid growth companies, including some that we currently own, are seeing sharp declines in share prices that appear to be divorced from the fundamental long-term attractions of these businesses. Contrary to the prevailing pessimistic sentiment, we are excited at the prospect of investing in these businesses. We remain confident that the inherent strengths of their business models will enable them to deliver attractive long-term returns for patient shareholders.

 

The principal risks and uncertainties facing the Company are set out following note 13 of this report.

 

 

Baillie Gifford & Co

 

 

 

 

Past performance is not a guide to future performance

 

 

 

 

Income statement (unaudited)

 

 

For the six months ended

31 July 2019

For the six months ended

31 July 2018

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Net gains on investments (note 3)

70,278 

70,278 

51,417 

51,417 

Currency losses

(3,736)

(3,736)

(2,829)

(2,829)

Income from investments

2,762 

2,762 

2,193 

2,193 

Investment management fee (note 4)

(1,511)

(1,511)

(1,465)

(1,465)

Other administrative expenses

(286)

(286)

(360)

(360)

Net return before finance costs and taxation

965 

66,542 

67,507 

368 

48,588 

48,956 

Finance costs of borrowings

(530)

-

(530)

(500)

(500)

Net return on ordinary activities before taxation

435 

66,542 

66,977 

(132)

48,588 

48,456 

Tax on ordinary activities (note 5)

(276)

(276) 

(219)

(219)

Net return on ordinary activities after taxation

159 

66,542 

66,701 

(351)

48,588 

48,237

Net return per ordinary share (note 7)

0.06p

24.18p

24.24p

(0.14p)

19.58p

19.44p

 

 

The accompanying notes on the following pages are an integral part of the Financial Statements.

The total column of this statement is the profit and loss account of the Company. The supplementary revenue and capital columns are prepared under guidance published by the Association of Investment Companies.

All revenue and capital items in this Statement derive from continuing operations.

A Statement of Comprehensive Income is not required as all gains and losses of the Company have been reflected in the above statement.

 

 

Balance sheet (unaudited)

 

 

At 31 July 2019

At 31 January 2019

(audited)

 

£'000

£'000

Fixed asset investments

 

 

Investments held at fair value through profit or loss (note 8)

556,901 

479,874 

 

 

 

Current assets

 

 

Debtors

1,427 

2,706 

Cash and cash equivalents

4,972 

5,750 

 

6,399 

8,456 

Creditors

 

 

Amounts falling due within one year

(1,007)

(2,229)

Net current assets

5,392 

6,227 

Total assets less current liabilities

562,293 

486,101 

 

 

 

Creditors

 

 

Amounts falling due after more than one year (note 9)

(55,956)

(51,946)

Total net assets

506,337 

434,155 

 

 

 

Capital and reserves

 

 

Share capital

5,530 

5,469 

Share premium account

168,611 

163,191 

Capital redemption reserve

21,521 

21,521 

Capital reserve

315,893 

249,351 

Revenue reserve

(5,218)

(5,377)

Shareholders' funds

506,337 

434,155

 

 

 

Net asset value per ordinary share

(after deducting borrowings at book value)

 

183.1p

 

158.8p

Ordinary shares in issue (note 11)

276,502,485 

273,452,485

 

 

 

 

Statement of changes in equity (unaudited)

 

 

For the six months ended 31 July 2019

 

Share
capital

£'000

Share
premium

account

£'000

Capital redemption

reserve

£'000

Capital

reserve*

£'000

Revenue reserve

£'000

Shareholders' funds

£'000

Shareholders' funds at 1 February 2019

5,469 

163,191 

21,521 

249,351 

(5,377)

434,155 

Ordinary shares issued (note 11)

61 

5,420 

5,481 

Net return on ordinary activities after taxation

66,542 

159 

66,701 

Shareholders' funds at 31 July 2019

5,530 

168,611 

21,521 

315,893 

(5,218)

506,337 

 

 

 

For the six months ended 31 July 2018

 

Share
capital

£'000

Share
premium

account

£'000

Capital redemption

reserve

£'000

Capital

reserve*

£'000

Revenue reserve

£'000

Shareholders' funds

£'000

Shareholders' funds at 1 February 2018

4,749

95,174

21,521

285,451

(5,483)

401,412

Ordinary shares issued (note 11)

437

41,436

-

-

41,873

Net return on ordinary activities after taxation

-

-

-

48,587

(351)

48,236

Shareholders' funds at 31 July 2018

5,186

136,610

21,521

334,038

(5,834)

491,521

 

 

*    The Capital reserve includes investment holding gains of £204,029,000 (31 July 2018 - gains of £261,503,000).

 

 

 

 

Condensed Cash Flow Statement (unaudited)

 

 

Six months to

31 July

2019

Six months to

31 July

2018

 

£'000

£'000

Cash flows from operating activities

 

 

Net return on ordinary activities before taxation

66,977 

48,456 

Net gains on investments

(70,278)

(51,417)

Currency losses

3,736 

2,829 

Finance costs of borrowings

530 

500 

Overseas withholding tax

(335)

(245)

Changes in debtors and creditors

676 

385 

Cash from operations

1,306 

508 

Interest paid

(502)

(477)

Net cash inflow from operating activities

804 

31 

Net cash outflow from investing activities

(7,320)

(42,933)

Ordinary shares issued

5,481 

43,255 

Net cash inflow from financing activities

5,481 

43,255 

(Decrease)/increase in cash and cash equivalents

(1,035)

353 

Exchange movements

257 

34 

Cash and cash equivalents at start of period

5,750 

5,668 

Cash and cash equivalents at end of period *

4,972 

6,055 

* Cash and cash equivalents represent cash at bank and short term money market deposits repayable on demand.

 

 

Twenty largest equity holdings at 31 July 2019 (unaudited)

 

 

Name

 

Business

Value

£'000

% of

total assets

Absolute performance *

%

Bengo4.com

Online legal consultation

16,628

3.0

36.5

Peptidream

Drug discovery and development platform

16,508

2.9

42.0

Outsourcing

Employment placement services

16,467

2.9

14.5

Istyle

Beauty product review website

16,080

2.9

7.8

GMO Payment Gateway

Online payment processing

15,473

2.8

52.6

Horiba

Manufacturer of measuring instruments

15,462

2.7

20.8

Asahi Intecc

Specialist medical equipment

15,461

2.7

31.4

Nihon M&A Center

M&A advisory services

15,117

2.7

17.5

Infomart

Internet platform for restaurant supplies

14,856

2.6

38.9

Katitas

Real estate services

14,676

2.6

48.1

Yume No Machi

Online meal delivery service

14,450

2.6

21.6

MonotaRO

Online business supplies

14,040

2.5

11.9

OSG

Manufactures machine tool equipment

12,509

2.2

6.6

Raksul

Internet based services

10,987

2.0

41.8

Brainpad

Business data analysis

10,785

1.9

29.5

Harmonic Drive

Robotic components

10,417

1.9

18.8

Nippon Ceramic

Electronic component manufacturer

10,386

1.8

23.0

Noritsu Koki

Holding company with interests in biotech and agricultural products

10,293

1.8

19.6

Shoei

Manufactures motor cycle helmets

9,737

1.7

30.6

Sho-Bond

Infrastructure reconstruction

9,617

1.7

5.9

 

 

269,949

47.9

 

 

*      Absolute performance is in sterling terms and has been calculated on a total return basis over the period 1 February 2019 to 31 July 2019.

Source: Baillie Gifford/StatPro and relevant underlying data providers.

 

 

  

 

Notes to the condensed financial statements (unaudited)

 

1.    

The condensed Financial Statements for the six months to 31 July 2019 comprise the statements set out on the previous pages together with the related notes below. They have been prepared in accordance with FRS 104 'Interim Financial Reporting' and the principles of the AIC's Statement of Recommended Practice issued in November 2014 and updated in February 2018 with consequential amendments and have not been audited or reviewed by the Auditor pursuant to the Auditing Practices Board Guidance on 'Review of Interim Financial Information'. The Financial Statements for the six months to 31 July 2019 have been prepared on the basis of the same accounting policies as set out in the Company's Annual Report and Financial Statements at 31 January 2019.

Going Concern

The Directors have considered the nature of the Company's principal risks and uncertainties, as set out below, together with its current position, investment objective and policy, its assets and liabilities and projected income and expenditure. The Company's assets, which are primarily investments in quoted securities which are readily realisable, exceed its liabilities significantly. All borrowings require the prior approval of the Board. Gearing levels and compliance with loan covenants are reviewed by the Board on a regular basis. Accordingly, the Directors considered it appropriate to adopt the going concern basis of accounting in preparing these Financial Statements and confirm that they are not aware of any material uncertainties which may affect the Company's ability to continue in operational existence for a period of at least twelve months from the date of approval of these Financial Statements.

2.    

The financial information contained within this Interim Financial Report does not constitute statutory accounts as defined in sections 434 to 436 of the Companies Act 2006. The financial information for the year ended 31 January 2019 has been extracted from the statutory accounts which have been filed with the Registrar of Companies. The Auditor's Report on these accounts was not qualified, did not include a reference to any matters to which the Auditor drew attention by way of emphasis without qualifying their report, and did not contain a statement under sections 498 (2) or (3) of the Companies Act 2006.

3.    

 

 

Six months to

31 July 2019

Six months to

31 July 2018

 

 

 

£'000

£'000

 

Net gains on investments

 

 

 

 

Gains on sales of investments

 

16,296 

12,187

 

Movement in investment holdings gains

 

53,982 

39,230

 

 

 

70,278 

51,417

4.    

Baillie Gifford & Co Limited, a wholly owned subsidiary of Baillie Gifford & Co, has been appointed by the Company as its Alternative Investment Fund Manager (AIFM) and Company Secretary. The investment management function has been delegated to Baillie Gifford & Co.  The management agreement can be terminated on six months' notice. On 1 January 2019 the annual management fee was reduced to 0.75% on the first £50m of net assets, 0.65% on the next £200m of net assets and 0.55% on the remainder calculated and payable quarterly. Prior to 1 January 2019, the annual management fee was 0.95% on the first £50m of net assets, 0.65% on the next £200m of net assets and 0.55% on the remainder.

5.    

The Company suffers overseas withholding tax on its equity income, currently at the rate of 10%.

6.    

No interim dividend will be declared.

 

 

Notes to the condensed financial statements (unaudited) (ctd)

 

7.    

 

 

Six months to

31 July 2019

Six months to

31 July 2018

 

 

 

£'000

£'000

 

Net return per ordinary share

 

 

 

 

Revenue return

 

159 

(351)

 

Capital return

 

66,542 

48,588 

 

Total return

 

66,701 

48,237 

 

Net return per ordinary share is based on the above totals of revenue and capital and on 275,146,822 (31 July 2018 - 248,142,402) ordinary shares, being the weighted average number of ordinary shares in issue during the period. There are no dilutive or potentially dilutive shares in issue.

8.    

Fair Value

The fair value hierarchy used to analyse the basis on which the fair values of financial instruments held at fair value through the profit or loss account are measured is described below. Fair value measurements are categorised on the basis of the lowest level input that is significant to the fair value measurement.

Level 1 -  using unadjusted quoted prices for identical instruments in an active market;

Level 2 -  using inputs, other than quoted prices included within Level 1, that are directly or indirectly observable (based on market data); and

Level 3 -  using inputs that are unobservable (for which market data is unavailable).

The Company's investments are financial assets held at fair value through profit or loss. An analysis of the Company's financial asset investments based on the fair value hierarchy described above is shown below:

 

Investments held at fair value through profit or loss

 

As at 31 July 2019

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

 

Listed equities

553,398 

553,398 

 

Unlisted securities

3,503 

3,503 

 

Total financial asset investments

553,398 

3,503 

556,901 

 

 

 

 

 

 

 

As at 31 January 2019

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

 

Listed equities

471,753

4,868 

476,621 

 

Unlisted securities

3,253 

3,253 

 

Total financial asset investments

471,753 

4,868 

3,253 

479,874 

                 

 

 

Notes to the condensed financial statements (unaudited) (ctd)

 

8. (ctd)

There have been no transfers between levels of the fair value hierarchy during the period. The fair value of listed investments is last traded price which is equivalent to the bid price on Japanese markets. Listed investments are categorised as Level 1 if they are valued using unadjusted quoted prices for identical instruments in an active market and as Level 2 if they do not meet all these criteria but are, nonetheless, valued using market data. Unlisted investments are valued at fair value by the Directors following a detailed review and appropriate challenge of the valuations proposed by the Managers. The Managers' unlisted investment valuation policy applies methodologies consistent with the International Private Equity and Venture Capital Valuation guidelines ('IPEV'). These methodologies can be categorised as follows: (a) market approach (multiples, industry valuation benchmarks and available market prices); (b) income approach (discounted cash flows); and (c) replacement cost approach (net assets). The Company's holdings in unlisted investments are categorised as Level 3 as unobservable data is a significant input to their fair value measurements.

9.    

The amounts falling due after more than one year include bank loans of £55,956,000 (¥7.45 billion) outstanding under yen loan facilities repayable on 27 November 2020 and 18 December 2024 (31 January 2019 - £51,946,000 (¥7.45 billion)).

10. 

The fair value of the bank loans at 31 July 2019 was £56,792,000 (31 January 2019 - £52,810,000).

11. 

The Company has the authority to issue shares/sell treasury shares at a premium to net asset value as well as to buy back shares at a discount to net asset value. During the period under review, 3,050,000 shares were issued at a premium to net asset value raising net proceeds of £5,481,000 (31 July 2018 - 21,875,000 shares raising net proceeds of £41,873,000). No shares were bought back during the period under review (31 July 2018 - nil).

12. 

Transaction costs incurred on the purchase and sale of the investments are added to the purchase cost or deducted from the sale proceeds, as appropriate. During the period, transaction costs on purchases amounted to £26,000 (31 July 2018 - £36,000) and transaction costs on sales amounted to £23,000 (31 July 2018 - £15,000).

13. 

Related party transactions

There have been no transactions with related parties during the first six months of the current financial year that have materially affected the financial position or the performance of the Company during that period and there have been no changes in the related party transactions described in the last Annual Report and Financial Statements that could have had such an effect on the Company during that period.

None of the views expressed in this document should be construed as advice to buy or sell a particular investment.

 

Principal Risks and Uncertainties

The principal risks facing the Company are financial risk, investment strategy risk, discount risk, regulatory risk, custody and depositary risk, small company risk, operational risk, leverage risk and political risk.

 

An explanation of these risks and how they are managed is set out on pages 8 and 9 of the Company's Annual Report and Financial Statements for the year to 31 January 2019 which is available on the Company's website: www.shinnippon.co.ukThe principal risks and uncertainties have not changed since the date of that report.

 

The Interim Financial Report will be available on www.shinnippon.co.uk and will be posted to shareholders on or around 26 September 2019.

Neither the contents of the Managers' website nor the contents of any website accessible from hyperlinks on the Managers' website (or any other website) is incorporated into, or forms part of, this announcement.

 

 

 

 

 

 

Glossary of Terms and Alternative Performance Measures (APM)

 

Total Assets

Total assets less current liabilities, before deduction of all borrowings.

 

Net Asset Value

Also described as shareholders' funds, Net Asset Value (NAV) is the value of total assets less liabilities (including borrowings). The NAV per share is calculated by dividing this amount by the number of ordinary shares in issue.

 

Net Asset Value (Borrowings at Book Value)

Borrowings are valued at adjusted net issue proceeds. The Company's yen denominated loans are valued at their sterling equivalent and adjusted for their arrangement fees. The value of the borrowings on this basis is set out in note 9 above.

 

Net Asset Value (Borrowings at Fair Value) (APM)

Borrowings are valued at an estimate of their market worth. The Company's yen denominated loans are fair valued with reference to Japanese government bonds of comparable yield and maturity. The value of the borrowings on this basis is set out in note 10 above.

 

 

31 July

 2019

31 January

2019

Net Asset Value per ordinary share (borrowings at book value)

 

183.1p 

 

158.8p 

Shareholders' funds (borrowings at book value)

£506,337,000 

£434,155,000 

Add: book value of borrowings

£55,956,000 

£51,946,000 

Less: fair value of borrowings

(£56,792,000)

(£52,810,000)

Shareholders' funds (borrowings at fair value)

£505,501,000 

£433,291,000 

Shares in issue at period end

276,502,485 

273,452,485

Net Asset Value per ordinary share (borrowings at fair value)

 

182.8p 

 

158.5p

 

Net Liquid Assets

Net liquid assets comprise current assets less current liabilities, excluding borrowings.

 

Discount/Premium (APM)

As stockmarkets and share prices vary, an investment trust's share price is rarely the same as its NAV. When the share price is lower than the NAV per share it is said to be trading at a discount. The size of the discount is calculated by subtracting the share price from the NAV per share and is usually expressed as a percentage of the NAV per share. If the share price is higher than the NAV per share, this situation is called a premium.

 

Total Return (APM)

The total return is the return to shareholders after reinvesting the net dividend on the date that the share price goes ex-dividend. The Company does not pay a dividend.

 

Ongoing Charges (APM)

The total expenses (excluding borrowing costs) incurred by the Company as a percentage of the average net asset value (with debt at fair value). The ongoing charges have been calculated on the basis prescribed by the Association of Investment Companies.

Gearing (APM)

At its simplest, gearing is borrowing. Just like any other public company, an investment trust can borrow money to invest in additional investments for its portfolio. The effect of the borrowing on the shareholders' assets is called 'gearing'. If the Company's assets grow, the shareholders' assets grow proportionately more because the debt remains the same. But if the value of the Company's assets falls, the situation is reversed. Gearing can therefore enhance performance in rising markets but can adversely impact performance in falling markets. Gearing represents its cash borrowings at par less cash and cash equivalents expressed as a percentage of shareholders' funds. Potential gearing is the Company's borrowings expressed as a percentage of shareholders' funds.

 

Leverage (APM)

For the purposes of the Alternative Investment Fund Managers (AIFM) Directive, leverage is any method which increases the

Company's exposure, including the borrowing of cash and the use of derivatives. It is expressed as a ratio between the

Company's exposure and its net asset value and can be calculated on a gross and a commitment method. Under the gross method, exposure represents the sum of the Company's positions after the deduction of sterling cash balances, without taking into account any hedging and netting arrangements. Under the commitment method, exposure is calculated without the deduction of sterling cash balances and after certain hedging and netting positions are offset against each other.

 

Active Share (APM)

Active share, a measure of how actively a portfolio is managed, is the percentage of the portfolio that differs from its comparative index. It is calculated by deducting from 100 the percentage of the portfolio that overlaps with the comparative index. An active share of 100 indicates no overlap with the index and an active share of zero indicates a portfolio that tracks the index.

 

 

Third party data providers disclaimer

 

No third party data provider ('Provider') makes any warranty, express or implied, as to the accuracy, completeness or timeliness of the data contained herewith nor as to the results to be obtained by recipients of the data. No Provider shall in any way be liable to any recipient of the data for any inaccuracies, errors or omissions in the index data included in this document, regardless of cause, or for any damages (whether direct or indirect) resulting therefrom.

No Provider has any obligation to update, modify or amend the data or to otherwise notify a recipient thereof in the event that any matter stated herein changes or subsequently becomes inaccurate.

Without limiting the foregoing, no Provider shall have any liability whatsoever to you, whether in contract (including under an indemnity), in tort (including negligence), under a warranty, under statute or otherwise, in respect of any loss or damage suffered by you as a result of or in connection with any opinions, recommendations, forecasts, judgments, or any other conclusions, or any course of action determined, by you or any third party, whether or not based on the content, information or materials contained herein.

 

MSCI Index Data

 

MSCI makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indexes or any securities or financial products. This document is not approved, endorsed, reviewed or produced by MSCI. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.

 

-Ends-


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
IR BUGDCGDBBGCI

a d v e r t i s e m e n t